Incidence and clinical significance of elevated liver function tests in cystic fibrosis clinical trials.

about

Incidence and clinical significance of elevated liver function tests in cystic fibrosis clinical trials.

Item

http://www.wikidata.org/entity/Q37628124

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Incidence and clinical signifi ...... stic fibrosis clinical trials.

@en

Incidence and clinical signifi ...... stic fibrosis clinical trials.

@nl

type

Item

label

Incidence and clinical signifi ...... stic fibrosis clinical trials.

@en

Incidence and clinical signifi ...... stic fibrosis clinical trials.

@nl

prefLabel

Incidence and clinical signifi ...... stic fibrosis clinical trials.

@en

Incidence and clinical signifi ...... stic fibrosis clinical trials.

@nl

P1476

Incidence and clinical signifi ...... ystic fibrosis clinical trials

@en

P2093

Bonnie W Ramsey

http://www.w3.org/2001/XMLSchema#string

Lisa Saiman

http://www.w3.org/2001/XMLSchema#string

Margaret Kloster

http://www.w3.org/2001/XMLSchema#string

Michael R Narkewicz

http://www.w3.org/2001/XMLSchema#string

Nicole Mayer-Hamblett

http://www.w3.org/2001/XMLSchema#string

P2860

The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosis

Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis.

Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'

A single centre experience of liver disease in adults with cystic fibrosis 1995-2006.

SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease

Liver disease in children with cystic fibrosis.

Serum hyaluronic acid concentrations are increased in cystic fibrosis patients with liver disease.

Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.

A pipeline of therapies for cystic fibrosis.

Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa.

P304

232-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCT.2012.11.005

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christopher H Goss

P577

2012-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23200843

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

3948320

http://www.w3.org/2001/XMLSchema#string